米诺卡的预测因素及其可能的机制
Mowei Kong1, Zhenying Pei1, Yuyu Xie2
1Department of Cardiology, Guiqian International General Hospital, Guiyang, Guizhou 550018, PR China.
Preventive medicine reports
|March 1, 2024
概括
带有非阻塞性冠状动脉的心肌梗塞 (MINOCA) 具有很高的不良事件风险,特别是在女性中. 像葡萄糖和脂质障碍等代谢因素显著影响MINOCA的预后.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 心血管研究研究心血管研究
背景情况:
- 带有非阻塞性冠状动脉的心肌梗塞 (MINOCA) 的特征是心肌缺血,没有显著的冠状动脉狭窄.
- 米诺卡带有严重的预后和长期并发症的高风险,需要进一步的临床调查.
研究的目的:
- 提供关于MINOCA的临床试验和研究的广泛概述.
- 为了解决MINOCA临床特征,长期前景,风险分层和预后心脏代谢因素的有限研究.
主要方法:
- 关于MINOCA的现有临床试验和研究的全面审查.
- 文献分析以区分MINOCA与心脏病患者的非阻塞性冠状动脉.
主要成果:
- 对于MINOCA患者来说,长期不良事件的风险很大.
- 由于社会生理因素,女性的医院死亡率和对MINOCA的敏感性更高.
- 葡萄糖和脂质代谢的障碍以及血清CysC水平的改变是影响MINOCA发生和预后的关键心脏代谢风险因素.
结论:
- 进一步的研究对于阐明MINOCA预后因素背后的复杂生物机制至关重要.
- 了解这些因素可以确定改善MINOCA预后和管理策略的潜在治疗目标.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K